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Abstract  
Acute kidney injury (AKI) is common in the perioperative and intensive care setting. 
Although AKI is usually multifactorial, haemodynamic instability, sepsis and drug 
toxicity are commonly implicated. Independent of the exact aetiology, several different 
pathophysiologic processes occur simultaneously and in sequence, including 
endothelial dysfunction, alteration of the microcirculation, tubular injury, venous 
congestion and intrarenal inflammation. A multitude of different immune cells from 
within the kidney and the systemic circulation play a role in the development, 
maintenance and recovery phase of AKI. 
In this review we describe the common processes involved in AKI and their 
connections with particular emphasis on the perioperative and critical care setting.  
 
 
 
 
 
Key words: acute kidney injury, pathophysiology, inflammation, endothelial 
dysfunction, tubular injury, microcirculation 
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Introduction 
Acute kidney injury (AKI) is a syndrome that encompasses many different aetiologies. 
In fact, most cases of AKI are multifactorial. Following an inciting event, various 
different pathophysiologic processes occur simultaneously as well as in sequence [1-3]. 
Not surprisingly, a multitude of different cell types from within the kidney and the 
systemic circulation are involved.  
In the following review, we will summarise key components of normal renal physiology 
and describe the most common processes leading to AKI, with a particular focus on the 
perioperative and critical care setting.  
 
 
Normal renal physiology 
In health, the kidneys receive 20% of the cardiac output. Blood flow within the kidneys 
is selectively distributed. Branching renal arteries terminate in glomerular afferent 
arterioles and form a capillary network responsible for glomerular filtration. 
Subsequent efferent arterioles follow one of two paths. Those that arise from 
glomeruli within the outer and mid-cortex give rise to a dense network of capillaries 
that run alongside the proximal and distal convoluted tubules. Efferent arterioles that 
arise from the inner or juxtamedullary glomeruli form the vasa recta which run parallel 
to the loops of Henle.  
 
Under these conditions, blood flow to the outer cortex is approximately 5-6 ml/g 
tissue/min whereas the outer and inner medulla only receive 1 and 0.5ml/g/min, 
respectively. In contrast to the outer cortex, where much of the blood flow is directed 
to glomerular filtration, the key roles of the peritubular microcirculation are to off-load 
oxygen, deliver nutrients to the tissues, return reabsorbed solutes and water to the 
systemic circulation and participate in the counter-current mechanisms that are 
necessary to permit the conservation of water.  
 
The complex arrangement of the microvasculature generates a gradient of decreasing 
oxygen tension between the renal cortex and the papillary tip that results in a state of 
relative hypoxia within the renal medulla. In addition, the counter-current 
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arrangement of arteries and veins facilitates arterial-to-venous oxygen shunting in the 
renal cortex and also from descending to ascending vasa recta in the renal medulla, 
both of which contribute to deoxygenation of the medulla [4, 5].  
 
The Na/K ATPase in the proximal tubules is responsible for active reabsorption of 
sodium and also transport processes for glucose, amino acids and other solutes; it is a 
major determinant of the oxygen requirement of the kidney (~80%) [6, 7]. As most of 
the reabsorption is dependent on the filtration rate, the majority of oxygen 
consumption is therefore directly dependent on the glomerular filtration rate (GFR).  
 
In health, renal blood flow is maintained in a wide range of renal perfusion pressures 
(60 – 100 mmHg) [8]. Autoregulation of renal blood flow is mediated chiefly through 
changes in pre-glomerular vascular tone of the afferent arteriole in response to an 
increase of the NaCl concentration in the tubular fluid, ie. the tubuloglomerular 
feedback (TGF) [9, 10]. Several neurohormonal processes are involved, including 
complex interactions between the sympathetic nervous system, vasodilators such as 
nitric oxide (NO) and prostaglandin E2 and vasoconstrictors such as endothelin, 
angiotensin II and adenosine [7]. Thus, when systemic arterial pressure falls within the 
autoregulatory range, renal blood flow, GFR and kidney oxygenation can be 
maintained by a combination of afferent arteriolar dilatation and efferent arteriolar 
constriction. When renal artery pressure is reduced further, the impact on kidney 
oxygenation depends on the balance between changes in renal blood flow on the one 
hand, and changes in GFR and sodium delivery to the renal tubule on the other. 
 
 
Common processes involved in the pathophysiology of AKI 
i) Haemodynamic instability 
Many observational clinical studies have demonstrated significant associations 
between systemic haemodynamic instability and the development and progression of 
AKI [8, 11-13]. Martin et al showed that adequate restoration of mean arterial pressure 
(MAP) in patients with septic shock was associated with restored urine output and 
improved creatinine clearance [12]. Similarly, the FINNAKI study demonstrated an 
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association between the time spent in relative hypotension and the development of 
AKI in patients with sepsis [13]. Asfar and colleagues showed that in patients with 
known chronic hypertension, a higher target blood pressure prevented the 
development of severe AKI during sepsis [15]. However, other studies have not 
reported an independent association between MAP and risk of AKI suggesting that the 
impact of hypotension may depend on the severity of illness and patient comorbidities 
[15, 16].  
 
In the perioperative setting, several studies found an association between 
intraoperative hypotension and development of postoperative AKI [17-19]. In a large 
retrospective analysis of more than 30,000 non-cardiac surgeries, hypotension during 
surgery (defined as a MAP < 55 mm Hg) was associated with an increased risk of AKI 
[17]. The risk increased with duration of hypotension and was significant for durations 
as short as 1 – 5 minutes. These results have been largely confirmed in other studies 
[18, 19]. In an analysis of 57,000 patients, Salmasi et al showed that a duration of a few 
minutes of intraoperative MAP below 65 mmHg was associated with AKI [19].  
 
Certain types of surgery are associated with a higher risk of renal hypoperfusion, in 
particular vascular surgery procedures in which the aorta is cross-clamped above the 
renal arteries. Though not as well described in human studies, in animal studies renal 
vein clamping also results in significant kidney injury [20]. In the setting of cardiac 
surgery, non-pulsatile flow during cardiopulmonary bypass may result in renal 
ischemia and contribute to the risk of AKI, together with systemic inflammation and 
release of free haemoglobin (as described below).  
 
 
ii) Microcirculatory dysfunction 
The concept of reduced renal blood flow as a main contributor to AKI is no longer valid 
since several studies in humans and animals demonstrated that AKI may develop 
during periods when renal blood flow was normal or even increased; instead, 
dysfunction of the intrarenal microcirculation appears to be more important [21]. 
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There are two specialised microcirculatory structures in the kidney, the glomeruli and 
peritubular microcirculatory networks, both of which have crucial roles in the 
development and propagation of AKI [7]. Because peritubular capillaries are derived 
from the efferent glomerular arterioles, any disturbance of glomerular blood flow will 
impair peritubular perfusion even when global renal blood flow is unchanged or even 
increased [22].  
 
Inflammatory diseases, including sepsis, can cause a profound alteration of 
microvascular function resulting in heterogeneous and sluggish flow. This may lead to 
patchy areas of hypoperfusion and micro-ischemia within the kidney even in the 
absence of global hypoperfusion. These focal perfusion deficits have been shown to be 
of greater magnitude in the highly vulnerable outer medulla compared with the cortex 
[22, 23]. Hypoxic zones may co-exist with intact regions with preserved tissue 
oxygenation, and interactions between these areas are thought to be associated with 
increased generation of reactive oxygen species (ROS) [24]. In addition, increased 
capillary permeability as a result of endothelial dysfunction can result in interstitial 
edema, which may both compromise microcapillary flow and increase the distance 
over which oxygen must diffuse. These alterations of microcirculatory flow can persist 
even when systemic hemodynamics are adequately corrected [25]. 
 
Recent experimental studies suggest that in septic AKI, there is also redistribution of 
flow away from the renal medulla to the renal cortex resulting in further medullary 
deoxygenation [26]. It is thought that activation of intra-renal shunting pathways may 
be responsible [1]. Although dysfunction of the microcirculation appears to play an 
important role in the pathogenesis of AKI, it remains unclear it is directly responsible 
for the development of AKI or rather an adaptive mechanism [27]. 
 
 
iii) Endothelial dysfunction 
The endothelium is a natural barrier between intravascular and extravascular spaces. 
Under physiologic conditions, endothelial cells perform several functions to maintain 
homeostasis and integrity of the endothelial barrier. By producing prostacyclin, NO and 
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other vasoactive substances, they influence the tone of arterioles and venules and 
inhibit platelet aggregation, thereby regulating the microcirculation and glomerular 
filtration. The integrity of the endothelial barrier prevents the passage of albumin and 
larger endogenous molecules in the urine. A key component of the endothelial barrier 
is the glycocalyx, a network of glycoproteins that lines the extracellular surface of the 
endothelial cells. Damage to the glycocalyx contributes to microvascular dysfunction, 
capillary leakage and impaired GFR [27, 28].  
 
Endothelial dysfunction plays a central role in microcirculatory dysfunction during 
sepsis. Following exposure to a variety of systemic inflammatory mediators, the 
endothelium undergoes structural changes with loss of cell-cell contact and disruption 
of the glycocalyx, resulting in increased permeability. In addition, activated endothelial 
cells up-regulate the expression of adhesion molecules resulting in increased 
adherence of leukocytes and enhanced leukocyte-endothelium interactions which 
leads to leukocyte transmigration toward the renal interstitium [29, 30]. Leukocytes 
leaving peritubular capillaries have a close proximity to tubular epithelial cells and can 
directly induce tubular cell injury [2]. During this process, endothelial and tubular cells 
continue to release pro-inflammatory cytokines which ultimately triggers a vicious 
circle of inflammatory processes [27, 31]. Within the microvasculature, there is marked 
plugging and heterogenous flow mediated by adherence of leukocytes to the 
endothelium and formation of microthrombi [32, 33]. In the perioperative setting, 
although the degree to which the endothelium is affected will vary by type of surgery, 
the role of endothelial dysfunction in the pathogenesis of AKI appears to be more 
limited. 
 
Apart from sepsis, the endothelium also plays an important role in primary renal 
diseases such as rapidly progressive glomerulonephritis or vasculitis. 
Histopathologically, the hallmark of these diseases is the formation of crescents.  
Crescents develop following the leakage of fibrin into the Bowman space as a result of 
increased permeability of the glomerular basement membrane. Fibrin stimulates the 
proliferation of cells of the Bowman capsule, and induces an influx of monocytes. As 
crescents grow, capillary loops are compressed and glomerular function ceases. 
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However, this is a unique class of kidney pathology that is uncommonly encountered in 
the perioperative setting but may be a potential cause of AKI in critically ill patients in 
the Intensive Care Unit (ICU). Typically, these diseases require a renal biopsy for 
diagnosis, in contrast to AKI that more typically occurs in the peri-operative setting or 
in the context of sepsis. 
 
 
iv) Formation of microvascular thrombi 
Under physiological conditions, endothelial cells inhibit blood coagulation through 
their interaction with protein C and thrombomodulin. Activation of coagulation is 
central to microcirculatory dysfunction. During an inflammatory response, many of the 
natural anticoagulants, including protein C, are degraded, or their production is 
decreased leading to a pro-coagulant state. Damaged endothelial cells may also 
undergo apoptosis which amplifies the coagulation cascade further. This disturbance 
of the procoagulant – anticoagulant balance is enhanced by pro-inflammatory 
cytokines, leads to formation of microthrombi and capillary plugging, and is typically 
seen in sepsis. Confocal microscopy studies in animal models of septic AKI have very 
elegantly demonstrated the presence of microvascular thrombi [34].  
 
A thrombotic microangiopathy is also classically seen in diseases associated with 
complement activation, for instance, haemolytic uraemic syndrome (HUS), thrombotic 
thrombocytopenic purpura (TTP) or pre-eclampsia [35]. In all cases, the thrombotic 
injury is often followed by an influx of inflammatory cells. Again, these conditions are 
rarely encountered in the perioperative setting but may be seen in patients admitted 
to the ICU.  
 
 
v) Inflammation 
Inflammation and recruitment of leukocytes are now recognised as key mediators of 
all phases of endothelial and tubular cell injury in the initiation and maintenance phase 
of AKI [3]. Immediately after endothelial or tubular epithelial cell injury, an immune 
response is triggered consisting of the activation of resident inflammatory cells and the 
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recruitment and subsequent invasion of white blood cells. Virtually all immune cells 
have been implicated in these pathophysiological processes of AKI. Most invading cells 
are thought to be deleterious (i.e., neutrophils, monocytes, dendritic cells) but some 
are likely protective (i.e., T regulatory cells) [36-38]. There are also some circulating 
cells whose role varies depending on the phase of the disease process [32]. For 
instance, M1 macrophages contribute to inflammation in the early phase, whereas M2 
macrophages exert anti-inflammatory functions post-ischaemia and facilitate renal 
recovery [39]. 
 
Systemic inflammation may also contribute to the pathogenesis of AKI – for example, 
elevated levels of interleukin-6 have been associated with the development of AKI in 
the setting of severe sepsis, cardiac surgery, and in critically ill patients with the acute 
respiratory distress syndrome [40-42]. Finally, intrarenal inflammatory processes can 
induce inflammatory changes in other non-renal organs, including the heart, lung and 
liver. These distant organ effects appear to be mediated through cytokines and 
activated immune cells [43].  
 
 
vi) Tubular cell injury 
Microcirculatory dysfunction leads to tubular cell injury. Another mechanism for 
tubular cells to get injured is through direct exposure with substances in the filtrate. By 
nature, tubular epithelial cells are at the frontline of filtered exogenous products (i.e., 
drugs) and endogenous molecules such as cytokines, danger-associated molecular 
patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs) [44]. During 
cardiac surgery with cardiopulmonary bypass, free haemoglobin may be released and 
cause tubular damage through direct toxicity as well as intratubular crystal formation 
[45, 46]. Independent of the exact aetiology, tubular cell injury often manifests itself in 
structural changes including apical membrane blebbing, opening of tight junctions, loss 
of polarity, cell detachment from the basement membrane and cell swelling. 
Mitochondrial damage may occur, too [46-48]. Increased mitochondrial fragmentation 
promotes the excess production of reactive oxygen species, release of cytokines and 
cellular death, all of which contribute further to the progression of AKI [49]. As such, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 10
tubular cells have diverse roles in AKI. They are the victims as well as promoters of 
inflammatory processes. In addition, they try to protect neighbouring cells by 
spreading alarm signals in a paracrine fashion [2, 51].  
 
At its extreme, tubular cell injury will result in cell death through a number of 
mechanisms, including necrosis and apoptosis. In human AKI, tubular cell injury 
typically predominates over frank cell death. As described, a number of mechanisms 
that contribute to tubular cell injury occur in the perioperative setting, and may 
culminate in AKI. 
 
Tubular damage itself can be associated with a significant decline in GFR despite a lack 
of damage to the glomerulus per se. A likely mechanism linking both processes is TGF. 
In the event of tubular cell damage or dysfunction, Na reabsorption in the proximal 
tubule is impaired resulting in increased delivery of NaCl to the macula densa. This 
triggers the TGF and leads to pre-glomerular vasoconstriction of the afferent arteriole 
resulting in a decline in GFR.  
 
 
vii) Renal venous congestion 
The kidney is an encapsulated organ. Elevated central venous pressure (CVP) and the 
resultant increased backward pressure negatively impact on renal function, mainly due 
to renal congestion and increased pressure along the renal vascular tree. This can lead 
to compression of tubules and a decrease in the net pressure gradient across the 
glomerulus, resulting in a fall in GFR [52, 53]. Most evidence stems from patients with 
congestive heart failure, cardiovascular disease and critical illness where an association 
between venous congestion and the development of AKI has been repeatedly shown 
[54-60]. Relevant to the perioperative setting, renal venous clamping has been shown 
in animal models to result in significant kidney injury, too [20].  
 
 
viii) Tubular obstruction   
Obstruction at any level from the tubules to urethra can cause AKI. A typical example 
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of tubular obstruction is crystal nephropathy following administration of drugs that 
are insoluble in urine, such as indinavir, acyclovir, sulfadiazine or methotrexate [61]. 
In addition to insolubility, factors such as urine pH, sluggish tubular urine flow rates, 
and rapid parenteral or excessive dosing enhance the risk for precipitation and 
crystal formation in the distal tubular lumen. Other examples of obstructive 
nephropathy are ureteric obstruction from nephrolithiasis or retroperitoneal fibrosis, 
or bladder outflow obstruction.  
 
In the perioperative setting, myoglobinuria and/or hemoglobinuria as a result of 
extensive tissue injury, hemolysis or extracorporeal circuits may also lead to 
intratubular cast formation and obstruction.  
 
 
 
ix) Auto-immune processes  
Several primary renal diseases are caused by circulating or newly formed immune 
complexes that deposit in the glomeruli and lead to an inflammatory reaction. Typical 
examples are lupus nephritis, post-infectious glomerulonephritis or Goodpasture 
syndrome. These are relatively rare causes of AKI in the peri-operative setting but may 
occasionally be encountered in patients in the ICU.  
 
 
x) Hypersensitivity immune reactions  
The high blood flow to the kidneys renders the tubular cells at increased risk of 
exposure to endogenous and exogenous substances, including drugs that may induce 
hypersensitivity reactions resulting in acute tubulo-interstitial nephritis [62]. In the first 
phase, either the resident peritubular interstitial cells or injured tubular epithelial cells 
can function as antigen presenters. The normally quiescent resident dendritic cells 
when exposed to antigens or damage signals are activated and endocytose, process, 
and express the incriminated antigenic components as peptides located on their 
surface. Once activated, dendritic cells migrate through the renal lymphatic vessels to 
regional lymph nodes where they present the antigen to the residual naïve T cells, 
which are then activated and migrate to the antigenic source or injury emitting the 
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danger signal. Dendritic cells have also been shown to take up small potentially 
antigenic molecules directly from the tubular lumen. In addition to the dendritic cells, 
the renal interstitium contains dormant macrophages and fibroblasts that may also be 
activated and contribute to an inflammatory response within the interstitium. The 
glomeruli and blood vessels are usually spared.  
 
Acute tubulo-interstitial nephritis is typically caused by a reaction to drugs but can also 
occur in the context of other inflammatory diseases like sarcoidosis, Sjögren’s 
syndrome or neoplastic diseases. As a result of interstitial expansion and tubular 
damage, renal function deteriorates. Importantly, the reaction is not dose-related but 
recurs on re-exposure to the same drug or one of its congeners. Common causes of 
interstitial nephritis that may be encountered in the operating theatre include non-
steroidal anti-inflammatory drugs and antibiotics, in particular pencillins and 
cephalosporins. 
 
 
xi) Intra-abdominal hypertension 
As intra-abdominal pressure increases, venous drainage of abdominal organs 
diminishes and venous congestion occurs [63]. For most patients, the critical intra-
abdominal pressure at which microcirculatory disturbance is observed is 10 to 15 
mmHg. In case of elevated renal vein pressure, intrarenal vascular congestion may 
induce AKI. If the intra-abdominal pressure continues to rise over 20mmHg (ie. 
abdominal compartment syndrome), additional factors, including reduction in 
cardiac output and elevated levels of catecholamines and inflammatory cytokines 
contribute to multi-organ failure, including AKI.   
 
 
Sequelae of AKI 
Under ideal conditions, renal function recovers fully after an episode of AKI. The 
timeline and trajectory of the renal recovery process will depend on reversal of the 
pathophysiological processes involved. However, it appears that under many 
circumstances, pro-fibrotic signals result in maladaptive repair and chronic kidney 
disease (CKD). Risk factors for maladaptive repair include increasing age, reduced 
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baseline renal function and prolonged duration and severity of AKI [64]. In the ICU 
setting, close follow-up of patients who suffer an episode of AKI is needed because 
these patients are at increased risk of multiple adverse events including CKD, end-
stage renal disease, re-hospitalizaton and death. However, the causal relationship 
between AKI and subsequent CKD remains controversial. In a recent secondary analysis 
of data from the CORONARY study, a large randomized clinical trial comparing off-
pump vs on-pump coronary artery bypass graft (CABG) surgery, off-pump CABG was 
associated with a lower rate of AKI but there was no difference in the incidence of CKD 
at one year [65]. Thus, whether AKI is causal or a marker of risk of CKD progression still 
needs to be further elucidated. 
 
 
Summary 
In most forms of AKI, the pathogenesis is characterised by an exacerbated 
inflammatory response, endothelial dysfunction, altered microcirculation and tubular 
injury. (Figure 1) An orchestra of different cells, inflammatory mediators and oxidative 
processes play a role, acting simultaneously as well as in sequence. 
 
Although most pathophysiological processes and relationships can explain the 
development of AKI in humans, it is important to remember that the majority of data 
stem from animals undergoing experiments that induce AKI. More work is necessary to 
verify current concepts in humans.  
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Practice points 
1. During the perioperative period, haemodynamic instability and hypotension are 
strongly associated with the development of postoperative AKI and should be 
avoided.  
2. AKI may develop during periods when renal blood flow is normal or even increased 
due to altered microcirculation within the kidney. 
3. Recruitment of leukocytes and intrarenal inflammation are key mediators of all 
phases of AKI but the role of anti-inflammatory therapies is unknown. 
4. Fluid overload and raised right atrial pressure are associated with the development 
of AKI, mainly due to renal congestion and increased intrarenal pressures and 
should be avoided or corrected. 
 
 
Research agenda 
• It is essential that knowledge acquired in idealized animal models is evaluated in 
human subjects with common comorbidities.  
• There is an urgent need to identify and measure inflammatory processes in human 
AKI in order to study the role of anti-inflammatory therapies for AKI. 
• It is important to identify the pathways implicated in microcirculatory dysfunction in 
humans to identify targets for therapeutic interventions.  
• There is a need to develop novel real-time methods to monitor the renal 
microcirculation in humans at risk of AKI.  
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Figure legend 
 
 
Figure 1:  Important pathophysiological processes involved in acute kidney injury 
 
Abbreviations: DAMPs = danger-associated molecular patterns; PAMPs = pathogen-
associated molecular patterns
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